NCT07055230View on ClinicalTrials.gov

Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA)

CompletedOBSERVATIONAL

Enrollment

67

Participants

Timeline

Start Date

January 8, 2022

Primary Completion Date

February 2, 2024

Study Completion Date

August 2, 2024

Conditions

Allergic Bronchopulmonary Aspergillosis (ABPA)

Trial Locations (1)

76031

University Rouen Hospital, Rouen

All Listed Sponsors

lead

University Hospital, Rouen

OTHER